DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
Quintiles IMS Holdings, Inc. (“QuintilesIMS”) (NYSE:Q) will announce its
fourth-quarter and full-year 2016 financial results and issue 2017
guidance before the market opens on Tuesday, February 14, 2017. The
QuintilesIMS management team will host a conference call and webcast at
9:00 a.m. Eastern Time on that date. The earnings release and
accompanying financial information will be posted on the QuintilesIMS
Investor Relations website at http://ir.quintilesims.com.
Interested parties are invited to listen to the live event and view the
presentation slides via webcast on the QuintilesIMS Investor Relations
website at http://ir.quintilesims.com.
The discussion also will be available by dialing +1-800-616-7436 in the
U.S. and Canada, or +1-303-223-4394 for international callers.
A replay of the webcast will be available approximately two hours after
the conclusion of the live event on February 14. To access the webcast
recording, visit http://ir.quintilesims.com.
About QuintilesIMS
QuintilesIMS (NYSE:Q) is a leading
integrated information and technology-enabled healthcare service
provider worldwide, dedicated to helping its clients improve their
clinical, scientific and commercial results. Formed through the merger
of Quintiles Transnational and IMS Health, QuintilesIMS’s approximately
50,000 employees conduct operations in more than 100 countries.
Companies seeking to improve real-world patient outcomes through
treatment innovations, care provision and access can leverage
QuintilesIMS’s broad range of healthcare information, technology and
service solutions to drive new insights and approaches. QuintilesIMS
provides solutions that span clinical to commercial, bringing customers
a unique opportunity to realize the full potential of innovations and
advanced healthcare outcomes.
As a global leader in protecting individual patient privacy,
QuintilesIMS uses healthcare data to deliver critical, real-world
disease and treatment insights. Through a wide variety of
privacy-enhancing technologies and safeguards, QuintilesIMS protects
individual privacy while managing information to drive healthcare
forward. These insights and execution capabilities help biotech, medical
device and pharmaceutical companies, medical researchers, government
agencies, payers and other healthcare stakeholders in the development
and approval of new therapies, and to identify unmet treatment needs and
understand the safety, effectiveness and value of pharmaceutical
products in improving overall health outcomes. To learn more, visit www.QuintilesIMS.com.
QUINTILESIMSFIN
Click
here to subscribe to Mobile Alerts for QuintilesIMS.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170131006143/en/
Source: Quintiles IMS Holdings, Inc.